NeuroOne sells tools doctors use for brain and pain procedures, and the big question is whether wider use of its newer treatment system can turn today’s small business into a much larger, steadier one. The upside hinges on partners and hospitals choosing its approach more often, while the main risk is that slow adoption could force more fundraising and delay the path to profitability.Read more
NeuroOne is trying to grow beyond its current brain treatment business into bigger pain and brain therapy markets, but it still relies heavily on one major distributor and faces long approval timelines. See why delays, competition, and partner risks could slow its expansion even as the long-term medical need keeps rising.Read more
A small medtech company is trying to grow beyond its early brain procedure business by pushing a newer tool through a big surgical distributor and moving into less invasive pain treatments. The upside depends on whether it can turn early interest in brain drug delivery and new pain uses into real, repeatable demand—without stumbling on partners, approvals, or cash needs.Read more
No trending discussion available.
NeuroOne Medical Technologies Corporation, a medical technology company, provides solutions for continuous electroencephalogram (cEEG) and stereoelectrocencephalography (sEEG) recording in the United States. The company also provides solutions for spinal cord stimulation, brain stimulation, drug delivery and ablation solutions for patients suffering from epilepsy, trigeminal neuralgia, Parkinson’s disease, dystonia, essential tremors, and chronic pain due to failed back surgeries and other pain-related neurological disorders. The company has a collaboration with the Department of Neurology’s Division of Epilepsy at the University of Minnesota Medical School to advance a study evaluating epilepsy therapies. The company is based in Eden Prairie, Minnesota.
